Clinical Trial Update: Ofatumumab With IVAC Salvage Chemotherapy in Diffuse Large B Cell Lymphoma Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating ofatumumab with IVAC salvage chemotherapy in patients with diffuse large B cell lymphoma (DLBCL) that has relapsed or is refract…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Ofatumumab (ofatumumab)

Snippet

Sponsor: Polish Lymphoma Research Group | Conditions: Diffuse Large B Cell Lymphoma | Phase 2 | Status: COMPLETED